University of Tokyo | GenomeWeb

University of Tokyo

The licenses cover IP related to a new CRISPR technology known as Cpf1, advanced forms of Cas9, and additional Cas9-based genome editing technologies.

Japanese researchers uncovered recurrent DUX4 fusions in adolescent or young adult cases of B-cell acute lymphoblastic leukemia, along with other new ALL fusions.

Filamentous fungi are used in a variety of industrial processes and genome editing could increase enzyme yield and efficiency. 

A trend towards more precise Cas9 activity promises spatial and temporal control over the nuclease and could reduce risky off-target activity in gene editing.

General Electric has been awarded

NEW YORK (GenomeWeb) – Using a phylogenetic-based approach to study the genomes of more than a dozen mammals, University of Tokyo researchers found that African elephants have the largest number of characterized olfactory receptor genes.

NEW YORK (GenomeWeb News) – A single gene appears to be the main culprit in a myeloid proliferation complication called transient abnormal myelopoiesis, or TAM, that's sometimes seen in individuals with Down syndrome, according to a study online yesterday in Nature Genetics, which used

NEW YORK (GenomeWeb News) – A pair of studies appearing in Nature Genetics yesterday reported on a number of variants linked to myeloma, including a variant located near a gene involved in telomere function and ones linked to the cohesin complex.

NEW YORK (GenomeWeb News) – A Japanese team has published an integrated genomic and transcriptomic analysis focused on a form of kidney cancer called clear-cell renal cell carcinoma.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Shimadzu and the University of Tokyo today announced a collaboration to develop technologies aimed at lipidomic biomarkers.

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.